Welcome to our dedicated page for Sealsq SEC filings (Ticker: LAES), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEALSQ Corp (NASDAQ: LAES) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a foreign private issuer. SEALSQ files reports on Form 6-K and uses shelf registration statements on Form F-3 and equity compensation registrations on Form S-8, as described in its submissions. These documents cover topics such as capital raises, listing changes, product milestones, and strategic collaborations related to its post-quantum semiconductor and security business.
For investors analyzing LAES, SEALSQ’s 6-K filings include information on the commercial adoption of its Quantum Shield QS7001 post-quantum secure chip and QVault TPM, preliminary unaudited revenue metrics, cash position updates, and pipeline disclosures. Other filings detail events such as the transfer of SEALSQ’s ordinary shares to The Nasdaq Global Select Market, registered direct offerings and concurrent private placements of ordinary shares and warrants, and governance changes including director resignations and senior appointments.
SEALSQ also uses 6-K exhibits to furnish press releases about strategic partnerships, joint ventures, and investments, for example its collaboration with WeCan on post-quantum KYC solutions and agreements related to a sovereign Indian post-quantum semiconductor platform. These filings are often incorporated by reference into the company’s registration statements, a fact noted within the documents themselves.
On Stock Titan, LAES filings are supplemented with AI-powered summaries that highlight key terms, structural features of offerings, and the business context of product and quantum ecosystem updates. Users can quickly locate SEALSQ’s latest 6-Ks, review historical disclosures, and connect them to related capital markets activity and technology milestones without reading every page in full.
SEALSQ Corp, a foreign private issuer based in the British Virgin Islands with principal offices in Switzerland, submitted a Form 6-K for September 2025. The filing furnishes three key exhibits: a press release dated September 9, 2025, a Half Year Report including Management’s Discussion and Analysis of financial condition and results of operations, and condensed consolidated financial statements as at June 30, 2025. The company also states that most of the information in the Half Year Report and all of the condensed consolidated financial statements are incorporated by reference into its existing Form F-3 and Form S-8 registration statements, as well as their related base prospectuses and any outstanding prospectus supplements.
Amendment No. 1 to Schedule 13G shows that WISeKey International Holding AG now holds 6,001,200 SEALSQ Corp (LAES) ordinary shares, equating to 4.85 % of the 123.7 million shares outstanding as of 30 Jun 2025. Because the economic stake has fallen below the 5 % threshold, Item 5 is tick-marked “Ownership of 5 percent or less.”
Despite the smaller ordinary-share position, WISeKey also owns 1,499,700 Class F shares. When combined with the ordinary shares, this block delivers 52.41 % of SEALSQ’s total voting power, leaving WISeKey in effective control of shareholder decisions. All voting and dispositive power over the disclosed ordinary shares is sole; there is no shared power reported.
The filing is informational only—no purchase, sale or agreement is disclosed—and is made under Rule 13d-1(c). Certified by CEO Carlos Moreira and CFO John O’Hara on 29 Jul 2025.
SEALSQ Corp (NASDAQ: LAES) has entered into a definitive agreement to raise approximately $60 million through a registered direct offering. On 14 July 2025 the company signed a Securities Purchase Agreement with institutional investors to issue 15 million Ordinary Shares at a combined price of $4.00 per share, each accompanied by one Class A and one Class B warrant.
Both warrant series are immediately exercisable, expire on 15 July 2032 and carry an exercise price of $4.60. Full exercise would add a further 30 million shares, taking total potential issuance to 45 million. The warrants include anti-dilution adjustments, cashless-exercise mechanics and a 4.99% (optionally 9.99%) beneficial-ownership cap. Class A warrants feature an additional Black-Scholes cash-put right upon a qualifying Fundamental Transaction.
Maxim Group LLC is acting as placement agent and will receive a 7% fee on gross proceeds plus up to $40,000 in reimbursable expenses. The transaction is being conducted under SEALSQ’s effective Form F-3 shelf (File No. 333-286098). Closing is expected on 15 July 2025, subject to customary conditions. The company does not intend to list the warrants on any exchange.
Investors gain clarity on near-term liquidity—net proceeds (after fees) will strengthen the balance sheet—yet face material dilution from the primary share issuance and any future warrant exercises.